Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 65 publications
RETINAL BLOOD VELOCITY AFTER INTRAVITREAL INJECTION FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION WITH OPTICAL COHERENCE TOMOGRAPHY USING SPECKLE ANALYSIS.
Journal: Retina (Philadelphia, Pa.)
Published: April 09, 2026
Ocular Blood Velocity Measurement With Optical Coherence Tomography Using Speckle Analysis.
Journal: Translational vision science & technology
Published: November 13, 2025
Medicine Access Programmes: what do patients think - a patient-reported outcome study on ribociclib in metastatic breast cancer in Australia.
Journal: Internal medicine journal
Published: February 16, 2024
Detection of TTR Amyloid in the Conjunctiva Using a Novel Fluorescent Ocular Tracer.
Journal: Translational vision science & technology
Published: February 15, 2024
Identification of Retinal Amyloid-Beta in Ex Vivo Human Glaucoma Eyes Using a Novel Ocular Tracer.
Journal: Journal of glaucoma
Published: December 12, 2023
Comparative meta-analysis of microsurgery versus endovascular therapy and bypass versus nonbypass techniques for blister-like aneurysms: enigmas of the supraclinoid internal carotid artery.
Journal: Journal of neurosurgery
Published: October 29, 2023
Pembrolizumab Plus Chemotherapy in Squamous Non-Small-Cell Lung Cancer: 5-Year Update of the Phase III KEYNOTE-407 Study.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: February 03, 2023
Corrigendum to "Pembrolizumab plus Olaparib in Patients with Metastatic Castration-resistant Prostate Cancer: Long-term Results from the Phase 1b/2 KEYNOTE-365 Cohort A Study" [Eur Urol 83 (2023) 15-26].
Journal: European urology
Published: December 17, 2022
Real-World Outcomes of Ribociclib and Aromatase Inhibitor Use in First Line Hormone Receptor Positive, HER2-Negative Metastatic Breast Cancer.
Journal: Clinical breast cancer
Published: July 16, 2022
Pertuzumab study in the neoadjuvant setting for HER2-positive nonmetastatic breast cancer in Australia (PeRSIA).
Journal: International journal of cancer
Published: June 26, 2022
Pembrolizumab plus Olaparib in Patients with Metastatic Castration-resistant Prostate Cancer: Long-term Results from the Phase 1b/2 KEYNOTE-365 Cohort A Study.
Journal: European urology
Published: February 22, 2022
Last Updated: 09/26/2026